The historical rank and industry rank for Bod Science's Days Payable or its related term are showing as below:
ASX:BOD'
s Days Payable Range Over the Past 10 Years
Min: 117.72 Med: 562.28 Max: 1709.33
Current: 1403.04
During the past 9 years, Bod Science's highest Days Payable was 1709.33. The lowest was 117.72. And the median was 562.28.
ASX:BOD's Days Payable is not ranked
in the Drug Manufacturers industry.
Industry Median: 90.835
vs ASX:BOD: 1403.04
Bod Science's Days Payable
declined
from Jun. 2024 (3,148.13) to Jun. 2025 (1,092.56).
It may suggest that Bod Scienceaccelerated paying its suppliers.
Bod Science Days Payable Related Terms
Bod Science Days Payable Historical Data
* Premium members only.
The historical data trend for Bod Science's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Bod Science's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Bod Science Days Payable vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Bod Science's Days Payable distribution charts can be found below:
* The bar in red indicates where Bod Science's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
Bod Science's Days Payable for the fiscal year that ended in Jun. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Bod Science (ASX:BOD) has a Days Payable of 1,092.56 as of Jun. 2025. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Bod Science and its competitors. This is 94% above median its historical median of 562.28. Over the past decade, Bod Science's Days Payable has ranged from 117.72 to 1,709.33.
Is Bod Science's Days Payable too high?
Bod Science's current Days Payable of 1,092.56 is 94% above median its 10-year median of 562.28. Over the past 10 years, this metric has ranged from a low of 117.72 to a high of 1,709.33. The Drug Manufacturers industry median Days Payable is 90.84. Bod Science's value of 1,092.56 is 1102.8% above this industry median. Overall, Bod Science has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does Bod Science's Days Payable compare to ZTS?
Bod Science's Days Payable of 1,092.56 can be compared against companies in the Drug Manufacturers industry. The industry median Days Payable is 90.84. Bod Science's value of 1,092.56 is 1102.8% above this benchmark. Historically, Bod Science's own Days Payable has ranged from 117.72 to 1,709.33 over the past decade. While the company's 10-year median is 562.28 vs. the industry median of 90.84, Bod Science has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Drug Manufacturers company?
The median Days Payable among Drug Manufacturers companies is 90.84, based on 920 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Bod Science's current Days Payable of 1,092.56 is 1102.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Bod Science and its competitors. For the Drug Manufacturers industry, the median Days Payable is 90.84 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Bod Science's current Days Payable is 1,092.56, which is 94% above median its own 10-year median of 562.28. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bod Science stock overvalued right now?
Bod Science (ASX:BOD) has a current Days Payable of 1,092.56. The stock's GF Value™ is A$0.04, compared to a current price of A$0.02 — trading 40% below its estimated fair value. The current Days Payable is 1,092.56, which is 94% above median its 10-year median of 562.28 and 1102.8% above the Drug Manufacturers industry median of 90.84. Bod Science's overall GF Score™ is 12/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Bod Science (ASX:BOD), the current Days Payable is 1,092.56 as of Jun. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Bod Science (ASX:BOD) Overvalued in 2026?
Based on GuruFocus' analysis, Bod Science stock appears to be undervalued.
The current stock price of A$0.02 is trading 40% below its estimated GF Value™ of A$0.04.
Key valuation signals for ASX:BOD:
Days Payable: 1,092.56 (94% above median its 10-year median of 562.28)
GF Value™: A$0.04 vs. price of A$0.02 (40% below fair value)
Industry Position: 1102.8% above the Drug Manufacturers median
No single metric tells the full story. See the ASX:BOD stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Bod Science Ltd is a healthcare company combining the power of nature and science to deliver cannabis-derived health and skincare products, designed to improve lives and transform the medicinal cannabis, CBD, and hemp market. The firm is focused on cannabis drug development and products. The company is focused on progressing Research and Development and a defined clinical trial pathway to commercialize and deliver premium, scientifically trusted products for the consumer and medical markets. It earned it profits and sales revenue from Australia even though have segment in UK, Europe and USA.
12GF Score
Get the complete analysis for ASX:BOD
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ASX:BOD has been successfully added to your 
